Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia is a research paper published in Journal of Natural Products (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 5R01CA140674
Cancer Prevention and Research Institute of Texas
Grant: RP140399
CCR NIH HHS
Grant: HHSN261200800001C
NCI NIH HHS
Grant: P30 CA142543
NCRR NIH HHS
Grant: S10 RR024757
NCI NIH HHS
Grant: R01 CA140674
NCI NIH HHS
Grant: HHSN261200800001E
National Institutes of Health
Grant: 1S10RR024757-01
Small Animal Bioluminescence and Fluorescence Imaging System (with 3D capability)
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
National Institutes of Health
Grant: 5R01CA140674-05
Chemotherapeutic Agents with Enhanced Selectivity for the Tumor Microenvironment
Mateon Therapeutics, Inc.
University Research Committee, Baylor University
Office of the Vice Provost for Research, Baylor University
FWCI
1.06
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
CCDC 1502383: Experimental Crystal Structure Determination